Moreover, in the seminal work by Clendening et al. (2010), it was demonstrated that overexpression of the rate-limiting enzyme of the MVA pathway and the target of the lipid-lowering drugs statins, HMGCR, promoted malignant transformation in BC. This evidence concerns the gene HMGCR and breast cancer.